Chemir Pharma Services recently changed its name to Azopharma in response to its extensive growth and commitment as a contract pharmaceutical services provider.  Azopharma is a FDA-registered and cGMP-compliant research and development organization that supports the development and commercialization of pharmaceutical, biotech and medical devices.

The company’s Phase 1 Express project allows pharmaceutical companies to form clinical trials and includes preformulation, formulation, analytical R&D, QC release, stability, manufacturing, packaging and labeling of clinical supplies for Phase 1 development.

“Timing is a critical factor on the road to successful clinical study,” says Phil Meeks, Azopharma CEO. “We can now assist our customers in all phases of drug development for Phase 1 clinical supplies. Our Phase 1 Express will raise the bar in the industry and bring unsurpassed speed to the development of clinical materials.”

For more information, visit www.azopharma.com.

 …